Overview

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

Status:
Terminated

Trial end date:
2018-05-22

Target enrollment:

Participant gender:

Summary

This pilot partially-randomized phase II trial studies how well Supportive Therapy in Androgen Deprivation (STAND) clinic works in improving health outcomes and managing side effects in patients with prostate cancer. Individualized counseling regarding exercise and dietary habits may help improve patient understanding, satisfaction, and overall lessen adverse impact on quality of life caused by androgen deprivation.

Phase:

Phase 2

Details

Lead Sponsor:

University of California, San Francisco

Collaborator:

National Cancer Institute (NCI)

Treatments:

Androgens
Goserelin
Hormones
Leuprolide
Prolactin Release-Inhibiting Factors
Triptorelin Pamoate